Population Council and Duchesnay Announce New International Li... - 01 December 2020 02:00

NEW YORK and BLAINVILLE, QC, Nov. 30, 2020 /PRNewswire-AsiaNet/-- Today the Population Council and Duchesnay announce an exclusive license agreement to make ANNOVERA(R) (segesterone acetate and ethinyl estradiol vaginal system), the first and only contraceptive fully under a woman's control to protect against un...

  RedHill Biopharma Expands U.S.-Based Manufacturing Capacity of... - 30 November 2020 09:00

TEL AVIV, Israel and RALEIGH, N.C., Nov. 30, 2020 /PRNewswire-AsiaNet / -- RedHill adds two more manufacturing partners, both U.S.-based, for large-scale manufacturing of opaganib, in preparation for potential emergency use applications as early as Q1/2021 The new collaborations follow recently announced collaboratio...

  VUNO Boasts its AI Solutions and Research Results at RSNA 2020 - 28 November 2020 03:00

SEOUL, Nov. 28, 2020 /PRNewswire-AsiaNet/ -- South Korean artificial intelligence (AI) developer VUNO Inc. announced that it will join the Radiological Society of North America 2020 (RSNA 2020), a week-long event scheduled to be open on Nov. 29. Taking this as an opportunity, VUNO will prese...

  European Medicines Agency Validates Application for Tepotinib ... - 27 November 2020 04:27

DARMSTADT, Germany, Nov. 26, 2020 /PRNewswire-AsiaNet/-- Merck, a leading science and technology company, today announced that the European Medicines Agency (EMA) has validated for review, the application for tepotinib for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) ...

  Haoma Medica Completes First-in-Human Trial for NaQuinate, a N... - 27 November 2020 03:31

LONDON, Nov. 26, 2020 /PRNewswire-AsiaNet/ -- Haoma Medica announced today the completion of a first-in-human trial for NaQuinate, a naphthoquinone carboxylic acid, which is being developed as a novel orally administered therapeutic for osteoporosis. The first-in-human trial initiated la...

  Approval of Phase I/II Clinical Trial of ATG-016 (Eltanexor), ... - 26 November 2020 17:42

SHANGHAI and HONG KONG, Nov. 26, 2020 /PRNewswire-AsiaNet/ -- Antengene Corporation Limited ("Antengene", HKSE stock code: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-inclass therapeutics in hematology and...

  Online 2020 Gangnam Medi Tour Festa to be Held Until Dec. 31 - 26 November 2020 00:54

SEOUL, South Korea, Nov. 17, 2020 /PRNewswire-AsiaNet/ -- - Participation by 105 medical tourism institutions from Oct. 24 to Dec. 31 - One-stop guide from website information to consultations and reservations Gangnam-gu, a district globally famous as Mecca for medical tourism, opened its 2020 Onli...

  Almirall announces collaborations with the University of South... - 25 November 2020 09:00

BARCELONA, Spain, Nov. 25, 2020 /PRNewswire/ AsiaNet/ -- AlmirallShare [https://sharedinnovation.almirall.com/], the open innovation platform of Almirall, S.A. (ALM) [http://www.almirall.com/], announces two new collaborations with the University of South Australia and the Fundació Institut de Recer...

  RedHill Biopharma to Present at Evercore ISI HealthCONx and Pi... - 25 November 2020 09:00

TEL AVIV, Israel and RALEIGH, N.C., Nov. 25, 2020 /PRNewswire-AsiaNet/ -- RedHill Biopharma Ltd. (https://www.redhillbio.com/RedHill/ ) (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it will present and participate at the following virtual conferences in December...

  MedAlliance announces successful completion of enrolment in IS... - 25 November 2020 01:30

NYON, Switzerland, Nov. 25, 2020/PRNewswire-AsiaNet/ -- MedAlliance has announced completion of patient enrolment in the ISABELLA Clinical Trial with SELUTION SLR(TM) 018 DEB (drug-eluting balloon) for the treatment of dysfunctional AV fistulas in end-stage renal failure patients undergoing hemodia...